Aprogen Pharma Announces Termination of Publishing Contract with Subsidiary 'Fortress M'
[Asia Economy Reporter Minji Lee] Aprogen Pharm announced on the 19th that the publishing contract for the mobile game 'Fortress M' by its subsidiary Aprogen Healthcare and Games has been terminated early. The suspension amount is approximately 7.6 billion KRW, accounting for 15% of the recent consolidated gross sales of the parent company.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The company stated, "Due to the termination of the publishing contract, the subsidiary's service for the game has ended, and sales in the first quarter of this year are expected to decrease." It added, "We plan to compensate for the sales gap by publishing 'Trove' and 'Dragon Raja' Origin, as well as additional new game publishing in the future."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.